No, CBD product line is an all natural proprietary blend created by Ronald Laborde, Feldetrex is on the back burner and not being utilized because of the necessity to have FDA approval. An introduction of synthetic based tablets/pills is planned for 2018, other than that all products being manufactured this year will be OTC and 50 state legal.
Auramedi didn't come through, their attention is primarily focused on PBPMS and expanding distribution/product line. Also, last interview Hartman mentioned two companies interested in possibly forming a partnership to further progress their cancer tech. Patent has been resubmitted for it which should be granted in the near future and humanizing testing is planned to resume in April, possibly sooner contingent on a partnership.
News 
Market Data 
Discover 
AI
